MT-303

· Myeloid Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MT-303, covering 2025-12-18 to 2025-12-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MT-303 in Adults With Advanced or Metastatic GPC3-Expressing Cancers, Including HCC [Phase 1]